Radiation alone (0, 2, 4, 6, or 8 Gy) or in combination with SPARCL1 overexpression restrained clonogenic formation in BFTC909 and the combined treatment had a synergistic anti-tumor effect (Figure 4D). The gene discussed is SPARCL1; the disease is neoplasm.